|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Received for publication, February 12, 1997, and in revised form, July 14, 1997)
From the Department of Physiology and Biophysics, Case Western
Reserve University, Cleveland, Ohio 44106-4970
In this contribution the kinetic mechanism and
substrate specificity of Escherichia coli diacylglycerol
kinase were examined. Steady state kinetic studies were carried out
under mixed micellar conditions using a novel continuous coupled assay
system. The kinetic data were consistent with a random equilibrium
mechanism, implying that diacylglycerol kinase catalyzes direct
phosphoryl transfer from MgATP to diacylglycerol. This was supported by
failure to detect an enzyme-phosphate covalent intermediate and by the observation that the bisubstrate analog adenosine
5 Escherichia coli diacylglycerol kinase
(DAGK)1 represents a
family of prokaryotic DAGKs that play an
important role in microbial physiology under conditions of
environmental stress (1-3). DAGK is also important because it plays a
central technological role in the most commonly used assay for
diacylglycerol in biological extracts (4). DAGK is structurally
distinct from other kinases. It is a homotrimer (5), has virtually no
detectable sequence homology to other kinases, and lacks sequence
motifs typically present in enzymes catalyzing phosphoryl transfer (6,
7). With a molecular mass of only 13 kDa, DAGK is easily the smallest known kinase. DAGK is an integral membrane protein with at least 50%
of its sequence being located within the lipid bilayer (Fig. 1). The reaction catalyzed by DAGK is
unique by virtue of its phase heterogeneity; ATP is water-soluble while
DAG is a bilayer-associated lipid.
Kinetic studies carried out in the laboratories of R. Bell and H. Sandermann have established that DAGK can be subjected to detailed mechanistic characterization in mixed micelles (8-11). Their work has provided a phenomenological characterization of DAGK's
apparent activation by metal ions and phospholipids. The Bell
laboratory also examined DAGK's diacylglycerol substrate specificity
in elegant detail (12). In this report, we present additional kinetic
studies that resolve the previously unaddressed question of whether
DAGK catalyzes direct phosphoryl transfer or employs an
enzyme-phosphate intermediate. The new kinetic data also allow us to
examine the question of whether or not DAGK is an evolutionarily
optimized biocatalyst in the sense that it can catalyze its reaction
near the substrate diffusion-controlled rate limit (13). In addition,
DAGK's nucleotide substrate specificity is scrutinized in
this study.
DAGK, in which the N-terminal Met
residue has been replaced with a MGHHHHHHEL "poly(His)" sequence
tag, was purified from a high level overexpressing strain of E. coli using nickel ion chelate chromatography as described
previously (14). For the studies of this work the final purification
step was elution of pure DAGK from the Ni(II)-agarose (Qiagen,
Chatworth, CA) column using a 1% For routine assays and for the kinetic
studies DAGK was assayed by enzymatically coupling its reaction to NADH
oxidation, a process conveniently followed in a continuous mode by
monitoring assay solution absorbance at 340 nm and 30 °C. Routine
assays were initiated by adding DAGK to assay mixtures containing pH 6.8 buffer (60 mM PIPES, 50 mM LiCl, 0.1 mM EDTA, 0.1 mM EGTA), 60 mM
For steady state kinetic studies the following modifications were made
to the standard assay: the PIPES concentration was somewhat higher (75 mM), the Mg2+ concentration was slightly higher
(20 mM), DMPC was replaced by 8 mol % (relative to
micellar OG) cardiolipin (beef heart mitochondrial, Avanti Polar
Lipids, Alabaster, Alabama), and the ATP and DHG concentrations were
variable.
Reactions involving ATP analogs were not run using the
coupled assay system because of the potential complication that some analogs might be poor substrates for pyruvate kinase, such that the
rate of the coupling enzyme could become partially rate-limiting. In
these cases, an assay in which pyrene-tagged DAG
(1-pyrenebutyryl-2-butyrl-sn-glycerol, PBBG) served as the
substrate for DAGK. At various time points during the reaction,
aliquots were quenched, and the pyrene-tagged product phosphatidic acid
was separated from PBBG using TLC. TLC plates were then subjected to
ultraviolet light, and the conversion of substrate to product was
quantified via densitometric analysis of the fluorescent spots on the
TLC plates. This assay has been described in detail previously (14).
For the studies of this report, TLC assay conditions were 24 ± 3 °C, pH 6.8, 60 mM PIPES, 50 mM LiCl, 0.2 mM EDTA, 0.2 mM EGTA, 20 mM
Mg2+, 21 mM DM (19 mM micellar), 5 mM DMPC, 1.25 mM PBBG, and 1-20 mM
ATP (or other triphosphate). When the triphosphate concentration was
greater than 5 mM, the Mg2+ concentration was
set to be equal to [triphosphate] + 20 mM.
The synthesis
of this bisubstrate analog involved phosphoester condensation of ATP
with activated dihexanoyl phosphatidic acid (DHPA, see Fig.
2). DHPA was synthesized from DHG by
reaction with POCl3, subsequent hydrolysis, and
purification by flash chromatography using 70:30:3:1
CHCl3:methanol:water:acetic acid. The RF of DHPA in this solvent system is ~0.45. DHPA was converted to an
organic-soluble salt by dissolving 0.26 mmol in 2 ml of
dimethylformamide and adding 0.62 mmol of tri-n-butylamine,
followed by solvent removal using rotary evaporation. The residue was
subjected to redissolution in 3 ml of DMF and rotary evaporation three
times. The tributylammonium salt of DHPA formed in this manner (0.62 mmol) was redissolved by 4 ml of DMF, and to this were added 1.4 mmol
of carbonyldiimidazole (Sigma) to activate DHPA for ester condensation.
The mixture was allowed to stir at 25 °C for 2 h followed by
heating at 40 °C for 1 h. Finally, 62 µl of methanol were
added to consume unreacted carbonyldiimidazole, and the mixture was
stirred for another hour at room temperature before repeated cycles of
solvent removal using rotary evaporation followed by redissolution of
the DHPA-imidazolamide in dimethylformamide.
Adenosine triphosphate (0.32 mmol) was converted to its pyridinium salt
form using Dowex 50W-X8 and then into its
tri-n-butylammonium form by dissolution in DMF followed by
addition of a 4.2 molar excess of tributylamine. Following repeated
redissolution in DMF and rotary evaporation, the ATP was taken up into
3 ml of DMF and added to the 0.26 mmol of DHPA-imidazolamide, also in 3 ml of DMF, and stirred under argon. After 40 h at room
temperature, no sign of desired product could be detected by TLC (5:2:3
1-butanol:acetic acid:water). The reaction was then warmed to 45 °C
and allowed to proceed for 12 h, at which point a high
RF (0.57) UV-absorbing spot was observed to be
present with an intensity greater than that of the ATP precursor
(RF near 0). The reaction mixture was then
rotary-evaporated and flash-chromatographed (5:2:3 1-butanol:acetic
acid:water). The major product pool was rotary-evaporated to yield
0.26 g of a yellow oil. The product exhibited an
RF of 0.22 in 5:2:1:2 1-butanol:water:acetic acid:ethyl ether and was flash-chromatographed using this solvent system. This time it was possible to resolve the "major product" into two major species ("high" and "medium"
RF products) and one minor product (lowest of the
three in RF terms), all with RF
values near 0.22. Following drying of the pools by rotary evaporation,
medium RF product weighed 33 mg. This oil was next
dissolved by an 1-propanol/water mixture and passed over 1-ml Dowex
50W-X8 (Na+ form) columns, followed by rotary evaporation
to yield a white solid. The identity of this products as an ATP-DAG
conjugate where adenosine is 5 DAGK reaction
rates measured in studies where both DAG and MgATP concentrations were
varied were fit by the steady state kinetic model for a two-substrate
random equilibrium enzyme (15),
where Reaction rates determined in the presence of the ATP-DAG bisubstrate
analog were fit by a random equilibrium-derived model (15) which
assumes: (i) that the analog is competitive with both substrates, (ii)
that binding of the analog to the completely free enzyme is much
tighter than to either binary complex or to the ternary complex (so
that only the dissociation constant for the analog to the free enzyme
needs to be treated), and (iii) the degree of synergism between
substrates is negligible (
Development of a Continuous Coupled Mixed Micellar Assay System for DAGK Because DAGK is an integral membrane protein and because one of its substrates is a lipid, previous kinetic studies of DAGK have relied upon the use of mixed micelles as a means to solubilize the enzyme and DAG. Extensive justification has previously been presented regarding the validity of using mixed micelles to mimic the lipid bilayer for detailed kinetic study of DAGK (8, 9) (also see "Materials and Methods") and other membrane enzymes (16). A limited number of DAGK assays have also been carried out in bilayers, which suggest that DAGK's activity in vesicles is similar to its activity in mixed micelles at similar levels of substrates (14). The studies of this report were greatly facilitated by integrating the
central aspects of the mixed micellar DAGK assay system developed by
Bell and his co-workers (17) with a classical kinase assay wherein
substrate phosphorylation is coupled to UV absorbance-detectable NADH
oxidation via the mediation of pyruvate kinase and lactic dehydrogenase
(18). This new assay method is much easier than the existing assay
methods (11, 17) and also provides a continuous means for
monitoring the DAGK reaction. In developing this assay several
observations were made. First, the measured rates for a given set of
assay conditions were linear with the quantity of DAGK added to the
assay, as expected. Secondly, the slopes of the
A340 versus time plots were linear
following sample mixing until nearly all of the NADH had been consumed.
Finally, provided that lactic dehydrogenase and pyruvate kinase are
present at levels of A very
fundamental question with regard to the mechanism of any kinase is
whether it catalyzes phosphoryl transfer via a direct substrate to acceptor pathway or whether it first catalyzes formation of an enzyme-phosphate intermediate followed by a second transfer of
the phosphoryl from enzyme to acceptor. In general, a mechanism involving a covalent enzyme-phosphate complex is expected to be reflected by ping-pong kinetic behavior where both substrates are not
bound at the same time. The direct transfer mechanism would be expected
to display "random equilibrium" or "ordered" kinetic patterns,
in either case involving formation of an enzyme-MgATP-DAG ternary
complex. We carried out kinetics where the concentrations of both
substrates were varied systematically. The data were fit by the random
equilibrium kinetic model (in direct form, see "Materials and
Methods"), the results of which were used to generate the double
reciprocal plots shown in Fig. 3.
Vmax was determined to be 50 ± 7 units/mg,
corresponding to a kcat of 12 s Fig. 3. Double reciprocal plots for two-substrate-variable steady state kinetic measurements for DAGK. Rates were measured at 30 °C in OG/DMPC mixed micelles using the spectrophotometrically detected coupled assay system. The actual computer fit reflected by this plot was of the nonreciprocal data to the direct random equilibrium model (Equation 1, see "Materials and Methods" and the first section of "Results"). A, each line represents one DAG concentration. B, each line represents one MgATP concentration. [View Larger Version of this Image (19K GIF file)]
The data appear to be reasonably well fit by the random equilibrium model and are clearly not consistent with ordered or ping-pong mechanisms, as can be qualitatively discerned in Fig. 3. This result supports the notion that either MgATP or DAG can bind to the enzyme in both the presence and absence of the other substrate and that the reaction likely proceeds through a direct MgATP to DAG transfer pathway. DAGK Is Inhibited by a Bisubstrate AnalogIf DAGK catalyzes
direct phosphoryl transfer from MgATP to DAG, then the binding sites
for these two substrates should be proximal and oriented so that the
A series of 10 rates were measured where the apparent concentration of the inhibitor was varied from 5 to 100 µM (0.01 to 0.26 mol %), ATP was varied from 0.16 to 0.94 mM, and DHG was varied from 0.4 to 3.1 mol %. As described under "Materials and Methods," these data were fit by a model that assumes the inhibitor to be competitive against both substrates (as expected for bisubstrate inhibition (25, 26). A variety of different fits were attempted in which, variously, the Km for the two substrates were either allowed to vary or were fixed to their predetermined values. Because, under the conditions of the mixed micellar assay, effectively all of the ATP-DAG bisubstrate analog will be associated with the mixed micelles (27), mole fraction units were used to express KI in these calculations. In all cases, the KI inevitably was determined to be in the 0.03-0.06 mol % range. For the specific fit where Vmax and Km were fixed to values determined in the studies of the previous section, a KI of 0.036 ± 0.01 mol % was determined, about two orders of magnitude lower than Km,DAG. It should be noted that when the above calculations were repeated using molar units to express the inhibitor concentration, an apparent KI was calculated to be in the 10-21 micromolar range, well below the MgATP's Km. These results demonstrate that the tetraphosphate-linked ATP-DAG bisubstrate analog is a reasonably good inhibitor of DAGK. These inhibition results reinforce the interpretation of the steady state kinetic data that DAGK catalysis occurs via direct phosphoryl transfer from MgATP to proximally associated DAG. Attempts to Detect a Covalent DAGK-Phosphate IntermediateTo provide final confirmation that the DAGK reaction does not involve an enzyme-phosphate intermediate, two additional experiments were carried out to attempt detection of a phosphoenzyme intermediate. First, pure DAGK was bound through its poly(His) tag to Ni(II)-agarose resin and bathed in a mixed micellar solution in which the enzyme is fully active followed by exposure to saturating levels of MgATP. The on-resin enzyme was then washed extensively using the same mixed micellar solution in the absence of ATP. Equivalents of 0.3 of PBBG (relative to the moles of bound DAGK) were then passed through the column and collected. Possible phosphorylation of the fluorescently tagged of the DAG was then assayed using the thin layer chromatography DAGK assay method (see "Materials and Methods") and using a highly sensitive chemical assay to see if any conversion to phosphatidic acid occurred when DAG passed through the column. Within the limits of detection by these methods (which could detect an ~1% conversion of PBBG to product), no phosphatidic acid product could be detected. A control experiment in which PBBG was passed through the DAGK column in the presence of MgATP yielded >50% conversion to phosphatidic acid. Since ATP hydrolysis by DAGK is slow (hours) on the time scale it took to run these experiments (minutes), these results provide no evidence for the presence of a DAGK-phosphate intermediate that could react with PBBG in the absence of nucleotide. In a second series of experiments, DAGK bound to the Ni(II)-resin was exposed under standard mixed micellar assay conditions to 5 mM MgATP and then washed with ATP-free solution, conditions in which an enzyme-phosphate intermediate would be expected to persist if present. The column was then extracted with 1% decyl maltoside containing 2% formic acid to release the DAGK and any associated phosphate. This resulting solution was then ashed and tested for the presence of phosphate using the method of Van Veldhoven and Mannaerts (28). Within the limits of detection (sensitive enough to detect a 1% population of phosphorylated DAGK within the total DAGK population), no phosphate could be detected. This result provides additional confirmation that the DAGK reaction does not involve a covalent intermediate. Nucleotide Specificity of DAGKThe nucleotide specificity of the DAGK reaction was investigated using the TLC/fluorescent assay system to measure reaction rates at four to eight concentrations of each MgATP analog examined. Both adenosine tetraphosphate and adenosine diphosphate were tested as alternate substrates for DAGK's forward reaction. MgADP is a very poor phosphoryl donor (Table I), exhibiting a >105 reduction in Vmax relative to MgATP. On the other hand, while adenosine tetraphosphate shows a substantially reduced affinity for DAGK relative to either MgADP or MgATP, once bound it is a much better substrate than MgADP (Vmax within a factor of 500 that of MgATP).
The ribose and adenine moiety specificities of DAGK were also probed.
2 Is DAGK an Evolutionarily Optimized Biocatalyst? In this work DAGK's kcat and Km were accurately determined. A key criterion of the classical definition of an "evolutionarily optimized enzyme" is that kcat/Km should approach the substrate diffusion rate limit for enzyme-substrate bimolecular association (13).2 In the case of an enzyme such as DAGK which has two substrates, the rate limit will be defined by the substrate for which the rate of diffusion-controlled bimolecular association is lower. For DAGK, DAG most likely sets the diffusion limit rather than MgATP. To understand this, we must examine DAGK's physiological role as a component of the "diglyceride cycle" (1). Phosphatidylglycerol (PG) is a major anionic lipid of E. coli and of many other bacteria (29). When E. coli and, most likely, all other bacteria having periplasms are subjected to even moderately low ionic strength, part of their metabolic response includes high level production of membrane-derived oligosaccharides (MDO) in their periplasmic space (1, 2, 30). One step of this pathway is the transfer of PG's phosphoglycerol head group in the outer leaflet of the cytoplasmic membrane to the nascent MDO, generating DAG as a by-product. It has been estimated that under resting conditions there are roughly 4 million PG molecules per E. coli cell, but that in response to a change in osmolarity from 0.15 to 0.07 osmolar about 10 million molecules of PG are consumed in MDO production (31). DAGK plays its essential metabolic role by converting the DAG produced during MDO biosynthesis to phosphatidic acid, which then reenters the primary lipid catabolic pathways of the microorganism (32). This conversion is necessary both so that PG can be rapidly replenished and to detoxify the cytoplasmic membrane of DAG, a lipid known for its ability to promote formation of nonbilayer lipid phases (see Sanders (33) and references therein). Based upon the above observations, it appears that the conditions under which natural selection has exerted pressure to optimize DAGK's catalytic efficiency are those experienced by the enzyme during high level MDO biosynthesis. Thus, it is the DAG concentration near steady state at the peak of MDO biosynthesis that is most relevant to DAGK's Km,DAG. Furthermore, it is the diffusion of DAG from its site of production on the periplasmic face of the membrane to DAGK's active site on the cytoplasmic face which represents the process which an evolutionarily optimized DAGK would have to be able to keep up with. It should be noted that DAGK's level of expression does not change in response to changes in solution osmolarity (34). In the absence of a functional DAGK, DAG accumulates in the cytoplasmic membrane of E. coli. When the concentration reaches a level of about 8 mol %, cells lose their ability to proliferate under conditions of low osmolarity (3). In the presence of DAGK, the DAG concentration is maintained at about 0.6 mol % under low osmolarity conditions, almost identical to DAGK's observed Km for forms of DAG resembling those actually found in E. coli (3, 9, 12, 34). To reach the active site of DAGK under the critical in vivo
conditions described above, DAG must first transverse the lipid bilayer. Almost certainly, this process occurs via spontaneous DAG
flip-flop. Despite extensive generation of mutants defective in almost
all known components of lipid metabolism in E. coli (31,
32), no phenotypes that we are aware of exhibit characteristics which
would be consistent with a defect in DAG bilayer transversal. Furthermore, the unimolecular rate constant for spontaneous
DAG flip-flop in both natural membranes (i.e. erythrocytes)
and in model membranes is rather rapid, roughly 50 s The rate of DAG transbilayer diffusion as estimated above almost
certainly represents the diffusion rate limit for DAGK-substrate bimolecular association. The second order rate constant for
two-dimensional lateral DAG diffusion to the active site of the enzyme
once it is on the same side of the membrane can be safely approximated to be within a factor of 100 (once a common standard state has been
chosen) to that of MgATP diffusing in three dimensions through solution
to reach the active site. This assertion is based upon two facts.
First, the diffusion coefficients exhibited by lipids in membrane
bilayers are a factor of about 10 lower than that for similarly sized
molecules in aqueous solutions (37). Second, while the rate of
unimolecular diffusion will be lower because of the increased viscosity
of the membrane, the probability of a DAGK-DAG complex forming upon a
DAG-DAGK collision will be a little higher than for MgATP because of
the reduced dimensionality of the bilayer (38) and because a membrane
protein and its lipid substrate will be predisposed for orientationally
correct collision by bilayer topological constraints (39). The second
order rate constant for MgATP diffusion to an enzyme active site is in
the range of 106-108
M For a form of diacylglycerol akin to that found in the inner membrane
of E. coli, dioleoylglycerol (12), DAGK's
kcat/Km catalysis can be
determined to be 12 s The fact that DAGK's kcat and kcat/Km,ATP are only modest when compared with the most efficient of water-soluble kinases (41, 42) reflects the fact that the evolutionary constraints placed upon DAGK are membrane-specific; DAGK does not have to be as "good" an enzyme because its membranous metabolic pathway cannot presently deliver substrate to the active site as rapidly as in many metabolic pathways involving water-soluble substrates. This observation may shed light upon a very puzzling quality of DAGK; despite the small size of this enzyme and the complexity of the reaction it catalyzes, the microbial isozymes for which sequences are available are often highly divergent (sequence identity for some pairs is <20%). Mutagenesis studies have also shown dramatic sequential plasticity in functional E. coli DAGK molecules (43). Perhaps this sequence divergence reflects the fact that DAGK is not required by natural selection to be as chemically sophisticated and is therefore more tolerant of variations in sequence space than are water-soluble kinases. This leads to an interesting and experimentally testable conclusion: using mutagenesis it should be possible to dramatically "improve" DAGK's catalytic efficiency as measured under mixed micellar conditions, where transbilayer flip-flop is not a factor and the diffusion limit is much higher than in vivo. Despite Its Structural Singularity, DAGK's Catalytic Mechanism Appears to Be Fairly ConventionalLike most kinases which involve non-diphosphonucleotide phosphoryl acceptors (44), DAGK catalyzes direct MgATP-to-acceptor phosphoryl transfer. The fact that DAGK's high nucleotide specificity is exhibited primarily in the form of reductions in kcat for ATP analogs supports the possibility that a conformational change occurs following the binding of one or both substrates prior to actual phosphoryl transfer. The fact that the tetraphosphate-linked bisubstrate analog was a good inhibitor also supports this possibility. If DAGK does undergo a substantial conformational change, then it is similar in this regard to other kinases catalyzing direct phosphoryl transfer (24, 45, 46). The purpose of this conformational change, as for other kinases, is probably to exclude water from the active site so that hydrolysis does not significantly compete with transfer. * This work was supported in part by National Institutes of Health Grant GM47485.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Established investigator of the American Heart Association (AHA
94001540). To whom correspondence should be addressed. Tel.: 216-368-8651; E-mail: crs4{at}po.cwru.edu.
1 The abbreviations used are: DAGK, diacylglycerol kinase; DAG, sn-1,2-diacylglycerol; DM, -decyl maltoside;
OG, -octyl glucoside; DMPC, dimyristoylphosphatidylcholine; DHG,
sn-1,2-dihexanoylglycerol; PBBG,
1-pyrenebutyryl-2-butyrl-sn-glycerol; DHPA,
sn-1,2-dihexanoylphosphatidic acid; DMF, dimethylformamide;
MDO, membrane-derived oligosaccharides; PG, phosphatidylglycerol;
PIPES, 1,4-piperazinediethanesulfonic acid.
2 Another key criterion has to do with the relative magnitudes of Km for the limiting substrate (i.e. DAG) and the in vivo substrate concentration. For enzymes operating in intracellular metabolic pathways, a "perfect" enzyme should have a Km, which is either near (for an effectively irreversible reaction) or higher than (for a reversible reaction) the in vivo substrate concentration (13). For enzymes such as DAGK, which operate in pathways where in vivo substrate and product concentrations vary according to environment (3, 34) and which may sometimes operate under reversible conditions and sometimes under irreversible conditions, it is not completely clear how to judge the degree of optimization of Km. Thus, in the report, we limit our discussion to the more strictly chemical component of catalytic perfection, the question of whether DAGK's reaction rate can approach the diffusion-controlled limit. We thank Lech Czerski for growing some of the DAGK-overexpressing E. coli used for these studies. We are highly indebted to the laboratory of James Bowie (UCLA) for providing us with the DAGK-overexpression system and for helpful discussion.
©1997 by The American Society for Biochemistry and Molecular Biology, Inc. This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||